111 related articles for article (PubMed ID: 2195946)
1. [Contribution of murine models of spontaneous lupus to the analysis of genetic factors in human disease].
Tron F
Ann Med Interne (Paris); 1990; 141(3):217-21. PubMed ID: 2195946
[TBL] [Abstract][Full Text] [Related]
2. Analysis of MHC class II genes in the susceptibility to lupus in New Zealand mice.
Rozzo SJ; Vyse TJ; David CS; Palmer E; Izui S; Kotzin BL
J Immunol; 1999 Mar; 162(5):2623-30. PubMed ID: 10072504
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
Drake CG; Rozzo SJ; Hirschfeld HF; Smarnworawong NP; Palmer E; Kotzin BL
J Immunol; 1995 Mar; 154(5):2441-7. PubMed ID: 7868910
[TBL] [Abstract][Full Text] [Related]
4. Dissection of the role of MHC class II A and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination.
Zhang D; Fujio K; Jiang Y; Zhao J; Tada N; Sudo K; Tsurui H; Nakamura K; Yamamoto K; Nishimura H; Shira T; Hirose S
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13838-43. PubMed ID: 15361580
[TBL] [Abstract][Full Text] [Related]
5. Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice.
Fujii T; Iida Y; Yomogida M; Ikeda K; Haga T; Jikumaru Y; Ninami M; Nishimura N; Kodera Y; Inada Y; Shirai T; Hirose S; Nishimura H
Genes Immun; 2006 Dec; 7(8):647-54. PubMed ID: 17024131
[TBL] [Abstract][Full Text] [Related]
6. Genetic basis of murine lupus.
Santiago-Raber ML; Laporte C; Reininger L; Izui S
Autoimmun Rev; 2004 Jan; 3(1):33-9. PubMed ID: 14871647
[TBL] [Abstract][Full Text] [Related]
7. Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus.
Rozzo SJ; Drake CG; Chiang BL; Gershwin ME; Kotzin BL
J Immunol; 1994 Aug; 153(3):1340-51. PubMed ID: 7913114
[TBL] [Abstract][Full Text] [Related]
8. Genetic and cellular basis of anti-DNA antibody synthesis in systemic lupus erythematosus of New Zealand mice.
Shirai T; Hirose S; Sekigawa I; Okada T; Sato H
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():11-20. PubMed ID: 3497267
[TBL] [Abstract][Full Text] [Related]
9. The contribution of I-Abm12 to phenotypic and functional alterations among T-cell subsets in NZB mice.
Naiki M; Yoshida SH; Watanabe Y; Izui S; Ansari AA; Gershwin ME
J Autoimmun; 1993 Apr; 6(2):131-43. PubMed ID: 8388689
[TBL] [Abstract][Full Text] [Related]
10. [Lupus erythematosus disseminatus, lesional mechanisms, pathogenesis and genetics].
Tron F; Gilbert D
Rev Prat; 1990 Sep; 40(21):1915-9. PubMed ID: 1978401
[TBL] [Abstract][Full Text] [Related]
11. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
[TBL] [Abstract][Full Text] [Related]
12. The contribution of H-2bm12 and non H-2 background genes on murine lupus in NZB.H-2bm12/b mice.
Watanabe Y; Yoshida SH; Ansari AA; Gershwin ME
J Autoimmun; 1994 Apr; 7(2):153-64. PubMed ID: 8037836
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
[TBL] [Abstract][Full Text] [Related]
14. Contribution of major histocompatibility complex (MHC) to upregulation of anti-DNA antibody in transgenic mice.
Song YW; Tsao BP; Hahn BH
J Autoimmun; 1993 Feb; 6(1):1-9. PubMed ID: 8457281
[TBL] [Abstract][Full Text] [Related]
15. Genetic and molecular genetic studies of murine and human lupus.
Steinberg AD; Klinman DM; Kastner DL; Seldin MF; Gause WC; Scribner CL; Britten JL; Siegel JN; Mountz JD
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():166-76. PubMed ID: 3497269
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of systemic lupus erythematosus--studies using disease models. 1. The effect of MHC on lupus nephritis in (NZB x NZW)F1--a therapeutic suggestion].
Sato H; Hirose S; Shirai S
Nihon Rinsho; 1984 Dec; 42(12):2791-5. PubMed ID: 6530763
[No Abstract] [Full Text] [Related]
17. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
18. The genetics of systemic lupus erythematosus: putting the pieces together.
Kelly JA; Moser KL; Harley JB
Genes Immun; 2002 Oct; 3 Suppl 1():S71-85. PubMed ID: 12215907
[TBL] [Abstract][Full Text] [Related]
19. [Animal models in lupus].
Meyer O
Rev Rhum Mal Osteoartic; 1981 Dec; 48(12):817-25. PubMed ID: 6801750
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
